Description

5H-Pyrrolo[1,2-A]Imidazolium, 1-[2-(2,4-Dichlorophenyl)-2-Oxoethyl]-6,7-Dihydro-3-Phenyl-, Chloride (9Ci) is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is valued for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring sophisticated molecular architectures. It is primarily utilized by research institutions and pharmaceutical manufacturers engaged in the development of new chemical entities and specialty fine chemicals. CAS number 366492-45-7 identifies this specific molecular entity.

Application

• Pharmaceutical Intermediate: Serves as a key precursor in the multi-step synthesis of complex drug candidates, especially those targeting central nervous system (CNS) disorders or infectious diseases.
• Organic Synthesis Research: Used in academic and industrial R&D laboratories for exploring new chemical reactions and constructing novel heterocyclic frameworks.
• Agrochemical Development: Potential application as an intermediate in the synthesis of advanced crop protection agents, leveraging its dichlorophenyl and imidazolium motifs.
• Material Science: Investigated for the development of specialty ionic liquids or functional materials due to its ionic character and aromatic system.
• Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for custom synthesis projects under cGMP conditions.

Basic Information

Product Name	5H-Pyrrolo[1,2-A]Imidazolium, 1-[2-(2,4-Dichlorophenyl)-2-Oxoethyl]-6,7-Dihydro-3-Phenyl-, Chloride (9Ci)
CAS No.	366492-45-7
Molecular Formula	C21H19Cl3N2O
Molecular Weight	421.74 g/mol
Synonyms	1-[2-(2,4-Dichlorophenyl)-2-oxoethyl]-3-phenyl-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-4-ium chloride; 5H-Pyrrolo[1,2-a]imidazolium, 1-[2-(2,4-dichlorophenyl)-2-oxoethyl]-6,7-dihydro-3-phenyl-, chloride; 366492-45-7; 1-(2-(2,4-Dichlorophenyl)-2-oxoethyl)-3-phenyl-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-4-ium chloride; Pyrroloimidazolium chloride derivative
EINECS	Contact for details

Quality Control

Our 5H-Pyrrolo[1,2-A]Imidazolium chloride is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing to ensure identity, purity, and consistency, meeting the stringent requirements for pharmaceutical intermediates. A comprehensive Certificate of Analysis (COA) is provided with every shipment, detailing results from HPLC, NMR, and other relevant analytical methods. We support development and commercial projects with material suitable for use under cGMP guidelines.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a dry environment to prevent degradation. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white powder or crystalline solid
Identification (HPLC)	Conforms to reference standard
Identification (NMR)	Conforms to structure
Assay (HPLC)	≥ 97.0%
Water Content (KF)	≤ 2.0%
Residual Solvents (GC)	Meets ICH Q3C guidelines
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.